Dr Olfat Berro, Area Head Middle East, Roche Pharmaceuticals, examines how healthcare systems across the Middle East are confronting a convergence of ageing populations, rising non-communicable disease burdens, and constrained fiscal environments – and makes the case that investing in health innovation, early intervention, and integrated care pathways is not merely a clinical imperative, but a measurable economic and societal strategy for the decade ahead.
“In many of the conversations we have with our partners and health leaders, I ask one question: are we…
